Monoclonal anti-human breast cancer antibodies
US5629197A · kind A · utility
57Cited by
5References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 1994 |
| Grant date | May 13, 1997 |
| Priority date | — |
| Expiry date | Aug 11, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/864
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Murine monoclonal antibodies are prepared and characterized which bind selectively to high molecular weight mucins by immunoprecipitation test and are IgGs or IgMs. Immunotoxins comprising the monoclonal antibody and cytotoxic moiety were produced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.